Sign in

NCT05850299Completed

Interest of Performing Two 6-minute Walk Tests at the End of a Pulmonary Rehabilitation Program, in COPD Patients.

Source: ClinicalTrials.gov · Last updated 19 Sept 2025 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

In pulmonary rehabilitation, the 6-Minute Walk Test (6MWT) is essential to assess the effects of the program on patients' health. Current guidelines don't recommend to perform two 6MWT at the end of pulmonary rehabilitation. However, a more recent study shows that two 6MWT should be performed at the end of the program to accurately and reliably assess patients' capacities. The aim of this study is to compare the results of two tests performed at the end of the program by COPD patients to find out whether there is a benefit of performing two 6MWT at the end of pulmonary rehabilitation.

Status (registry)
Completed
Study type
Observational
Enrollment
176 (actual)
First submitted
28 Apr 2023
Start date
24 Mar 2023
Primary completion date
1 Apr 2024
Lead sponsor
University Hospital, Brest
Diseases
COPD
NCT number
NCT05850299

What you commit to

  • Study type: Observational
  • Participants enrolled: 176
  • From 24 Mar 2023 to the primary completion date, 1 Apr 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • Contraindication to perform the 6-Minute Walk Test
  • Patient under legal protection
  • Refusal of participation

Who the study is looking for

  • Patient with stage 2 to 4 (A to D) COPD
  • Admitted to pulmonary rehabilitation unit of CH des Pays de Morlaix (CHPM)
  • To follow a pulmonary rehabilitation program (4 weeks)
  • Patient aged 18 or over
  • Patient able to formulate his non-opposition to participate in the study

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Chu Brest
Coordinator of this site? Confirm its status
BrestFranceUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.